Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 220 participants.

Also called NCT06207383

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06207383
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Belgium, Bulgaria, Czechia, Finland, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06207383. Randomized; single masking; primary purpose treatment. Start 2024-10-01 (actual); primary completion 2028-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
Acronym
ABACUS
Condition
Atrial Fibrillation, Persistent
Condition
Heart Failure
Intervention (Device)
Conduction system pacing
Intervention (Procedure)
Atrioventricular nodal ablation
Intervention (Procedure)
Atrial fibrillation ablation
Lead sponsor
University Hospital, Geneva (class: other)
Collaborator
Swiss National Science Foundation (class: other)

Record details

Record id
cardio:ct-nct06207383
Content hash
d2311e7ab64d779bfabc08b9e1b8edcca500abf1895806a3e9a39cc637dc38af